Contact us

Our Services

Seda Clinical Manufacturing Services provides end-to-end Solutions for Clinical Trials. We provide comprehensive services for the establishment, testing, manufacturing, and distribution of oral dosage forms for clinical trials. Our integration with the Pharmaceutical Development Services division ensures a seamless transition into clinical phases, managed by a single, accountable Project Leader.


Manufacturing Services

Our GMP manufacturing capabilities are delivered through 5 grade D cleanrooms, designed to accommodate discrete equipment process chains allowing for flexible, multi-product manufacture to be executed simultaneously, with the highest standards of product containment.

We use globally recognised technology providers such as Bonapace, RoTab, Freund Vector and Procept to deliver complex, scalable oral solid dosage forms.

Our servicesinclude:

  • Tablet Manufacture: Small to mid-scale blending, granulation, compression and coating
  • Capsule Filling: Solid, liquid and semi-solid formulations, from very small (semi-manual) to mid-scale automated filling.
  • Spray drying: Amorphous solid dispersions from aqueous and solvent systems.

We follow a structed New Product Introduction process to ensure a seamless transition from early feasibility to robust clinical manufacture.


Analytical Services

Our analytical and Quality Control services ensure the highest standards of quality and compliance:

  • Raw Material Testing: Identity, purity, and potency testing.
  • In-Process Control: Real-time sampling and analysis.
  • Finished Product Testing: Chemical, physical, and microbiological testing.
  • Stability Testing: Determination of shelf life and storage conditions, including long-term, intermediate, and accelerated studies.
  • Method Development and Validation: Accurate and reliable testing methods using state-of-the-art equipment and techniques.
  • Documentation and Compliance: Comprehensive documentation for all QC activities, ensuring full traceability and compliance with regulatory standards. Our meticulous record-keeping supports audits and inspections, providing peace of mind to our clients.

QA Services

Our experienced Quality Professionals, including Qualified Persons (QPs), work alongside our clients to safeguard product quality, streamline manufacturing processes, and support regulatory submissions. We maintain a modern, fully electronic Pharmaceutical Quality System (PQS) which forms the backbone of our regulatory compliance framework.

Our QA services include:

  • Quality Assurance Support: Addressing quality-related issues and ensuring regulatory compliance through documentation review/approval, QP certification/confirmation and regulatory assistance
  • Regulatory Compliance: Guidance to help clients meet the requirements of MHRA, FDA, EMA and ICH guidelines, from clinical trial approval to market entry.
  • GMP Compliance: Strict adherence to Good Manufacturing Practices (GMP) ensuring that all of our operations meet the highest standards of compliance.
  • Documentation Control: Managing the creation, review, and maintenance of all essential documentation for regulatory submissions, including batch records,  Standard Operating Procedures (SOPs) and Batch certifications (COAs, COCs).
  • Risk Minimisation: Our focus on compliance, documentation, and quality management reduces potential risks, allowing your clinical trials to move forward without unnecessary delays.

Ask our team a question

Paul W Stott

BPharm (Hons) PhD

Chief Executive Officer

Paul W Stott

BPharm (Hons) PhD

Chief Executive Officer

View Bio Ask me a question

Paul is an established pharma executive with extensive global experience. Prior to joining Seda he was Vice President, Global Product Development at AstraZeneca, leading a group of over 350 scientists and engineers in the development of all products, manufacturing processes and analytical methods for the AstraZeneca small molecule portfolio.

AstraZeneca Global Product Development has centres in the UK, Sweden, US and China and a network of partnerships with colleagues all over the world and under Paul’s stewardship registered 10 global products.

At AstraZeneca Paul was accountable for the Drug Product CMC component of all Due Diligence assessments and was CMC lead on several multibillion dollar acquisitions. In addition, Paul is a visiting Professor of Pharmaceutics at the University of Manchester, UK and founder of the North West Centre for Drug Delivery (NoWCADD) at the University.

He is a proven senior manager and strategic leader in Pharmaceutical Development with experience across geographical boundaries. Passionate about the development of individual and group capabilities and the application of innovation and scientific rigour to bring new medicinal products to market.

He is recognised within the Industry and with Regulatory Agencies as a driving force in the establishment and realisation of best practice in CMC Quality by Design.

‪Paul Stott‬ – ‪Google Scholar‬

Ask me a question

    Expect a reply typically within 48 hours.

    Marcel de Matas

    BSc (Hons) PhD FRSC CChem

    Chief Technology Officer & Co-Founder

    Marcel de Matas

    BSc (Hons) PhD FRSC CChem

    Chief Technology Officer & Co-Founder

    View Bio Ask me a question

    Marcel has a track record in a range of management and senior scientific positions in industry and academia. Most recently he was a Principal Scientist in Product Design and Innovation at AstraZeneca, where he was responsible for introducing the latest science, new technologies (advanced drug delivery and manufacturing) and product design thinking into the Product Development group.

    Marcel has led technical activities, provided project leadership and has managed product development teams responsible for the delivery of drug projects from initial concept design through late stage development, regulatory submission and launch (including advanced drug delivery systems). He has led teams at the drug discovery-development interface, assessing the level of chemistry manufacturing and controls (CMC) technical risk and defining product design strategies in early development. Project experience has covered projects across a range of disease and therapy areas with substantial experience in the oncology field.

    ‪Marcel de Matas‬ – ‪Google Scholar‬

    Ask me a question

      Expect a reply typically within 48 hours.

      Vijay Masaun

      BSc (Hons)

      Director, Quality Assurance

      Vijay Masaun

      BSc (Hons)

      Director, Quality Assurance

      View Bio Ask me a question

      Vijay is an experienced Quality Professional with a distinguished career marked by several senior quality roles within various pharmaceutical organisations primarily in the CDMO/CMO space.

      His comprehensive understanding of the pharmaceutical landscape, coupled with his strategic thinking, has enabled him to navigate the complexities of the evolving industry standards.

      Vijay has a proven track record spanning over 9 years in the pharmaceutical industry as well as training to be a Qualified Person (QP), which will bring valuable experience to the Seda GMP team and ensuring a commitment to upholding regulatory standards.

      Ask me a question

        Expect a reply typically within 48 hours.